WEST CONSHOHOCKEN, Pa. (AP) — WEST CONSHOHOCKEN, Pa. (AP) — Madrigal Pharmaceuticals Inc. (MDGL) on Thursday reported a loss of $57.9 million in its second quarter.
The West Conshohocken, Pennsylvania-based company said it had a loss of $1.99 per share.
The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $2.55 per share.
The biopharmaceutical company posted revenue of $364.3 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $349.3 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MDGL at https://www.zacks.com/ap/MDGL
/Space/Rocket%20launching%20into%20space%20by%20BEST%20BACKGROUNDS%20via%20Shutterstock.jpg)
/A%20Palantir%20office%20building%20in%20Tokyo_%20Image%20by%20Hiroshi-Mori-Stock%20via%20Shutterstock_.jpg)
/Close-up%20shot%20of%20Rivian%20R1T_%20Image%20by%20Trong%20Nguyen%20via%20%20Shutterstock_.jpg)
